Search research articles
Contact Us
Filters
Showing results (791-800 of 910) with videos related to
Page
of 91
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 16, 2008
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins
Unni M Breland, Bente Halvorsen, Johanna Hol, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 22, 2022
Limited association between infections, autoimmune disease and genetic risk and immune activation in severe mental disorders
Maren Caroline Frogner Werner, Katrine Verena Wirgenes, Alexey A Shadrin, et al.
JACC. Heart Failure
|
April 1, 2017
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
Ståle H Nymo, Pål Aukrust, John Kjekshus, et al.
International Journal of Cancer
|
August 25, 2019
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers
Marianne E Nome, Leslie R Euceda, Shakila Jabeen, et al.
Biochemical and Biophysical Research Communications
|
September 21, 2024
Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling
Maria Belland Olsen, Mieke C Louwe, Kuan Yang, et al.
Circulation
|
February 7, 2007
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
Tuva B Dahl, Arne Yndestad, Mona Skjelland, et al.
Plos One
|
April 19, 2013
Association of ficolin-3 with severity and outcome of chronic heart failure
Zoltán Prohászka, Lea Munthe-Fog, Thor Ueland, et al.
Plos One
|
September 27, 2013
Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity
Trygve Holmøy, Kristin Ingeleiv Løken-Amsrud, Søren Jacob Bakke, et al.
Scientific Reports
|
March 28, 2020
Rosuvastatin alters the genetic composition of the human gut microbiome
Martin Kummen, Ole Geir Solberg, Christopher Storm-Larsen, et al.
Circulation Research
|
October 25, 2011
Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity
Isabelle T M N Daissormont, Anette Christ, Lieve Temmerman, et al.
Page
of 91
Search research articles
Search
Showing results (791-800 of 910) with videos related to
Sort By:
Page
of 91
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 16, 2008
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins
Unni M Breland, Bente Halvorsen, Johanna Hol, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 22, 2022
Limited association between infections, autoimmune disease and genetic risk and immune activation in severe mental disorders
Maren Caroline Frogner Werner, Katrine Verena Wirgenes, Alexey A Shadrin, et al.
JACC. Heart Failure
|
April 1, 2017
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
Ståle H Nymo, Pål Aukrust, John Kjekshus, et al.
International Journal of Cancer
|
August 25, 2019
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers
Marianne E Nome, Leslie R Euceda, Shakila Jabeen, et al.
Biochemical and Biophysical Research Communications
|
September 21, 2024
Continuous infusion of resolvin D2 in combination with Angiotensin-II show contrary effects on blood pressure and intracardiac artery remodeling
Maria Belland Olsen, Mieke C Louwe, Kuan Yang, et al.
Circulation
|
February 7, 2007
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
Tuva B Dahl, Arne Yndestad, Mona Skjelland, et al.
Plos One
|
April 19, 2013
Association of ficolin-3 with severity and outcome of chronic heart failure
Zoltán Prohászka, Lea Munthe-Fog, Thor Ueland, et al.
Plos One
|
September 27, 2013
Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity
Trygve Holmøy, Kristin Ingeleiv Løken-Amsrud, Søren Jacob Bakke, et al.
Scientific Reports
|
March 28, 2020
Rosuvastatin alters the genetic composition of the human gut microbiome
Martin Kummen, Ole Geir Solberg, Christopher Storm-Larsen, et al.
Circulation Research
|
October 25, 2011
Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity
Isabelle T M N Daissormont, Anette Christ, Lieve Temmerman, et al.
Page
of 91